| Product Code: ETC6188443 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Plaque Psoriasis Market in Australia covers pharmaceutical and biologic treatments targeting this chronic autoimmune skin disorder. Market growth is supported by rising prevalence, advances in targeted therapies, and improved diagnostic methods. Patients benefit from new-generation treatments offering better symptom control and fewer side effects, while increasing healthcare expenditure on dermatology drives demand.
The plaque psoriasis market in Australia is expanding with increased diagnosis rates and the availability of advanced biologic therapies. Patient demand for effective, targeted, and safer treatment options has led to the introduction of novel drugs such as IL-17 and IL-23 inhibitors. Telemedicine and digital health platforms are improving disease management and patient adherence. Additionally, public health awareness and support programs contribute to earlier diagnosis and better treatment outcomes.
The Australia Plaque Psoriasis Market faces challenges due to the chronic nature of the disease, requiring long-term treatment adherence. Side effects of existing therapies and the high cost of biologics limit patient compliance. Additionally, social stigma and delayed diagnosis prevent timely treatment, impacting overall market growth.
Investment in this pharmaceutical segment centers on developing novel biologics, topical therapies, and phototherapy solutions for plaque psoriasis. Growing awareness and diagnosis rates offer expanding market opportunities, especially for personalized medicine approaches. Biotech startups and pharmaceutical companies with R&D capabilities stand to benefit most.
The governments healthcare policies shape the plaque psoriasis market by funding research, ensuring access to innovative treatments, and regulating pharmaceuticals. The Pharmaceutical Benefits Scheme (PBS) plays a critical role by subsidizing approved psoriasis medications, making treatments more affordable. Policies also promote patient education and specialist care services.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Plaque Psoriasis Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Plaque Psoriasis Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Plaque Psoriasis Market - Industry Life Cycle |
3.4 Australia Plaque Psoriasis Market - Porter's Five Forces |
3.5 Australia Plaque Psoriasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Australia Plaque Psoriasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Australia Plaque Psoriasis Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Australia Plaque Psoriasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Plaque Psoriasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of plaque psoriasis in Australia |
4.2.2 Rising awareness about treatment options and therapies among patients and healthcare providers |
4.2.3 Advancements in medical technology leading to the development of innovative treatments |
4.3 Market Restraints |
4.3.1 High cost of biologic medications for plaque psoriasis treatment |
4.3.2 Limited access to specialized dermatologists in rural areas of Australia |
4.3.3 Side effects associated with some plaque psoriasis treatments |
5 Australia Plaque Psoriasis Market Trends |
6 Australia Plaque Psoriasis Market, By Types |
6.1 Australia Plaque Psoriasis Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Australia Plaque Psoriasis Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Australia Plaque Psoriasis Market Revenues & Volume, By Topical therapy, 2021- 2031F |
6.1.4 Australia Plaque Psoriasis Market Revenues & Volume, By Phototherapy, 2021- 2031F |
6.1.5 Australia Plaque Psoriasis Market Revenues & Volume, By Systemic agents, 2021- 2031F |
6.1.6 Australia Plaque Psoriasis Market Revenues & Volume, By Biologic therapies, 2021- 2031F |
6.1.7 Australia Plaque Psoriasis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Plaque Psoriasis Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Plaque Psoriasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Plaque Psoriasis Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3 Australia Plaque Psoriasis Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Australia Plaque Psoriasis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Plaque Psoriasis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Australia Plaque Psoriasis Market Revenues & Volume, By Speciality centres, 2021- 2031F |
6.3.5 Australia Plaque Psoriasis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Plaque Psoriasis Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Plaque Psoriasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Australia Plaque Psoriasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Australia Plaque Psoriasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Plaque Psoriasis Market Import-Export Trade Statistics |
7.1 Australia Plaque Psoriasis Market Export to Major Countries |
7.2 Australia Plaque Psoriasis Market Imports from Major Countries |
8 Australia Plaque Psoriasis Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed treatment regimens |
8.2 Number of new treatment options introduced in the market |
8.3 Patient satisfaction with the effectiveness of treatments |
8.4 Number of dermatologists specializing in plaque psoriasis in Australia |
8.5 Rate of adoption of telemedicine services for managing plaque psoriasis |
9 Australia Plaque Psoriasis Market - Opportunity Assessment |
9.1 Australia Plaque Psoriasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Australia Plaque Psoriasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Australia Plaque Psoriasis Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.4 Australia Plaque Psoriasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Plaque Psoriasis Market - Competitive Landscape |
10.1 Australia Plaque Psoriasis Market Revenue Share, By Companies, 2024 |
10.2 Australia Plaque Psoriasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here